ANG Lifesciences clarifies unusual price movement to BSE

ANG Lifesciences India Ltd responded to an email from BSE Limited dated April 09, 2026, seeking clarification regarding a significant movement in the company's share price. The company informed BSE that there is no additional price-sensitive information or announcement that, in its opinion, could have influenced the price/volume behavior of its scrip. ANG Lifesciences stated that the movement in price is purely market-driven, and the company has no control over or knowledge of such factors. The company also reiterated its commitment to regularly disseminating all required price-sensitive information and disclosures in accordance with SEBI regulations.